滬鼎產(chǎn)品文獻:桿菌肽(Bacitracin)ELISA試劑盒引用文獻
【文獻標題】GLP-1 receptor regulates cell growth through regulating IDE expression level in
Aβ1-42-treated PC12 cells
【作者】Huajie Li,Liping Cao,Yi Ren,et.al
【作者單位】常州第yi人民醫(yī)院神經(jīng)內(nèi)科(Department of Neurology, the First People’s Hospital of Chang Zhou, Jiang Su)
【文獻中引用產(chǎn)品】
桿菌肽(Bacitracin)ELISA試劑盒
【關(guān)鍵詞】GLP-1 receptor, IDE expression, Alzheimer's disease, type 2 diabetes
【DOI】doi.org/10.1042/BSR20171284
【影響因子(IF)】2.9
【出版期刊】《Bioscience Reports》
【產(chǎn)品原文引用】
Cell culture and treatments
PC12 cells were obtained from Shanghai Institute for Cell Research, Chinese Academy of Sciences. The cells were grown in DMEM supplemented with 10% foetal bovine serum and 1% antibiotics(penicillin/streptomycin, Sigma-Aldrich, St Louis, MO, USA) in a humidified atmosphere of 95% air and 5% CO2 at 37°C. The medium was changed every 2-3 days. Aβ1-42 oligomers were obtained from Sigma (Sigma-Aldrich, St Louis, MO, USA) and were added to cell cultures at a final concentration of 0, 1.25, 2.5, 5 and 10 μM. Gen was obtained from the National Institute for the Control of Pharmaceutical and Biological Products and was added to cell cultures at a final concentration of 0, 0.1, 1.0 and 10 μM. For treatment with IDE antagonist bacitracin (Bac), PC12 cells were incubated with 1 mg/L Bac (Shanghai Huding technology Co., Ltd., China) for 30 min. For PKA inhibitor experiment, PC12 cells were treated with 20 μM H89 (Calbiochem, La Jolla, CA), which was prepared as a 4 mM stock solution in DMSO.
完整版PDF文獻請咨詢在線客服或者聯(lián)系我司業(yè)務(wù)員!
更多公司福利請關(guān)注“上海滬鼎”vx公眾號!
相關(guān)產(chǎn)品
免責聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負責,不承擔此類作品侵權(quán)行為的直接責任及連帶責任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品第一來源,并自負版權(quán)等法律責任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。